Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *


ATC
ATC Description

ATC

ATC Code ATC Description
L01XK05 L01XK05 Veliparib
L01XK06 L01XK06 Pamiparib
L01XK07 L01XK07 Senaparib
L01XK52 L01XK52 Niraparib and Abiraterone
L01XL L01XL Antineoplastic cell and gene therapy
L01XL01 L01XL01 Sitimagene ceradenovec
L01XL02 L01XL02 Talimogene laherparepvec
L01XL03 L01XL03 Axicabtagene ciloleucel
L01XL04 L01XL04 Tisagenlecleucel
L01XL05 L01XL05 Ciltacabtagene autoleucel
L01XL06 L01XL06 Brexucabtagene autoleucel
L01XL07 L01XL07 Idecabtagene vicleucel
L01XL08 L01XL08 Lisocabtagene maraleucel
L01XL09 L01XL09 Tabelecleucel
L01XL10 L01XL10 Nadofaragene firadenovec
L01XL11 L01XL11 Lifileucel
L01XL12 L01XL12 Obecabtagene autoleucel
L01XM L01XM Isocitrate dehydrogenase (IDH) inhibitors
L01XM01 L01XM01 Enasidenib
L01XM02 L01XM02 Ivosidénib
L01XM03 L01XM03 Olutasidenib
L01XM04 L01XM04 Vorasidenib
L01XX L01XX Other antineoplastic agents
L01XX01 L01XX01 Amsacrine
L01XX02 L01XX02 Asparaginase
L01XX03 L01XX03 Altretamine
L01XX05 L01XX05 Hydroxycarbamide
L01XX07 L01XX07 lonidamine
L01XX08 L01XX08 Pentostatin
L01XX09 L01XX09 Miltefosine
Showing 30 of 7196 Records